glp-1 cardiovascular outcomes news Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action Cardiovascular Protective Properties of GLP-1
Description
Malkowski began her career in Naturopathic Medicine
A commission may be earned if you purchase through links in this article, at no additional cost to you
Clinical uses of GLP-1: Obesity and its link to unhealthy aging Obesity is a significant modifiable contributor to unhealthy aging, accelerating the onset of CVDs, T2D, neurodegeneration, and certain cancers through chronic inflammation, oxidative stress, mitochondrial dysfunction, and disrupted insulin signaling
Overall glucose variability increases, making blood sugar less predictable
The goal is to make the most of what you can eat and get the most bang for your buck in nutrition
Nausea is the most common side effect, especially when starting treatment
